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ABSTRACT: Many veterans engaged in care with the Veterans Administration (VA)
health system are also enrolled in Medicare and/or Medicaid and may receive care both
inside and outside of the VA. Use of dual health systems has been associated with worse
outcomes. Veterans with human immunodeficiency virus (HIV) may have different rates
of Medicare and Medicaid enrollment, and may be at greater risk of poor outcomes
related to non-VA use. This study compares the frequency of Medicare and/or Medicaid
enrollment and factors associated non-VA use in an HIV-infected and uninfected
population of veterans.

We used data from the VA and Center for Medicare & Medicaid Services from 2004 and
2005 to determine the frequency of Medicare and/or Medicaid enrollment among a cohort
of HIV-infected and uninfected veterans engaged in VA care. We then restricted the
study population to veterans enrolled in fee-for-service (FFS) Medicare and/or Medicaid
with at least one hospitalization, and identified characteristics associated with non-VA
hospital admissions.
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HIV-infected veterans had higher rates of Medicare and/or Medicaid enrollment than
uninfected veterans (38% vs. 33%, p<0.01), though the opposite was true when our
sample was limited to veterans 65 years and older (53% vs. 70%, p<0.0 1). Among
veterans enrolled in the VA and FFS Medicare and/or Medicaid, veterans with HIV had
greater illness severity and more frequent hospitalizations, but were less likely to be
hospitalized outside the VA (48% vs. 54%, p<0.01). HIV infection was associated with
lower odds of outside hospitalization (OR=0.76 [95% CI: 0.68, 0.85]).

Veterans with HIV have higher rates of Medicare and/or Medicaid enrollment, but lower
odds of non-VA hospitalization. The VA integrated model of HIV care may encourage
“inside” health care use among HIV-infected veterans.
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Introduction
Overview of 1995 Reform
In the mid-1990s, the Veterans Health Administration (VHA) responded to decreased
demand and a reputation for disorganization and poor quality with a comprehensive
reform of its care delivery system. It reorganized its hundreds of medical centers and
clinics into 23 regional, vertically integrated care networks (Veteran’s Integrated Service
Network or VISNs), adopted new technologies including electronic medical records
(EMR), implemented capitation funding, and placed new emphasis on primary care.
These moves, which presaged changes seen in the larger U.S. healthcare system today,
were aimed at improving care coordination, quality and patient experience.

At the VA, improvement in care coordination was driven by primary care. Historically,
the VA had focused more on hospital based medicine and specialty care that veterans had
difficulty finding in the community. However, recognizing that that their patient
population was aging and the increasing prevalence of chronic diseases, the VA changed
its physician mix through increased hiring of primary care providers (PCP) and support
staff. In 1995, prior to the reforms, only about 10% of veterans were assigned a primary
care provider. Four years later, essentially all patients were assigned a PCP and a primary
care team, and more than 80% of veterans could name their PCP [1]. These primary care
teams were accountable for the health of their patients and were aided by systems put in
place to support sharing of information. These included increase physician notifications
and involvement of primary care teams in hospital admissions, ER, urgent care and
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specialist visits, case management, and a shared EMR. EMR technology was also
leveraged to develop performance measures and quality improvement programs.

An evaluation of quality of care at VA after the implementation of these reforms found
year-to-year improvement in metrics assessing preventive medicine, as well as outpatient
and inpatient care. It also found that the VA outperformed fee-for-service Medicare in
nearly all of these metrics [2].

Background
Although VA reforms have led to demonstrable success in care coordination and quality,
its progress is affected by high rates of enrollment in outside insurance programs.
Previous work has described Medicare and/or Medicaid (“CMS enrollment”) and
identified factors that influence non-VA use (“CMS use”) among veterans eligible for
VA care, particularly those 65 years and older that have age qualified for Medicare [3-6].
These studies have shown rates of Medicare enrollment among veterans 65 years and
older exceeding than 90% [3], and identified factors such as distance to the VA, priority
status, and health status contribute to decisions to seek non-VA care [4].

Less well characterized is the frequency of CMS enrollment among veterans actively
utilizing VA care, and the factors that contribute to their decision to utilize dual health
systems, including veterans under age 65 and those enrolled in Medicaid. An expansion
of Medicaid coverage under the Patient Protection and Affordable Care Act of 2010
(ACA) will likely lead to an increase in the proportion of CMS enrolled veterans [7]. Use
of non-VA health care among veterans already engaged in VA care has been shown to
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lead to waste [8], as well as fragmented, lower quality care, and increased mortality [912].

Use of dual health systems is particularly worrisome for patients with complicated
chronic conditions like HIV. As HIV-infected veterans age they are vulnerable to adverse
outcomes because of the complexity of their care needs, including multimorbidity,
polypharmacy, mental health issues, and substance use [13-15]. Moreover, people living
with HIV are more likely to qualify for Medicare through disability than age, and
Medicare currently provides coverage for approximately one-fifth of the people receiving
HIV care in the U.S. [16]. Medicaid coverage for HIV varies on a state-to-state basis, but
it currently covers about 50% of the people receiving HIV care in the U.S. [17].

The VA is the largest provider of care for persons with HIV in the United States, with
over 20,000 veterans in care, and significant resources have been invested to create an
integrated HIV care model [18, 19]. The integrated model for HIV care in VA includes
on-site pharmacy services and emphasizes case management; and it also provides access
to coordinated medical and behavioral health care services, including mental health care,
urgent care, and substance abuse treatment. Previous research has demonstrated the
success of the integrated care model at the VA – showing higher rates of viral load
suppression in clinics with greater integration of care [15]. Given the high, and
potentially expanding, rates of CMS enrollment in the HIV population, an understanding
of Medicare and Medicaid enrollment and the frequency and drivers of CMS use among
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HIV-infected veterans accessing VA care is necessary to inform efforts to coordinate
care.

Statement of Purpose
The objectives of this paper were to: 1) determine the frequency of Medicare and/or
Medicaid enrollment among HIV-infected, compared with uninfected veterans, veterans
engaged in VA care; 2) determine the frequency of non-VA hospital admissions among
male, CMS enrolled HIV-infected and uninfected veterans with any hospitalizations; and
3) identify characteristics that predict non-VA hospital admission among male HIVinfected veterans, compared with uninfected veterans, enrolled in Medicare and/or
Medicaid. We hypothesized that the integrated system of care HIV-infected veterans
receive at the VA would lead to less non-VA use among CMS enrolled HIV-infected
veterans than their uninfected counterparts.

Methods
This retrospective cohort study included two source populations of veterans in VA care in
the United States during 2004 and 2005: 1) HIV-infected veterans; and 2) age, race and
facility-matched uninfected comparators.

We used data from the Veterans Aging Cohort Study (VACS), a multi-site, prospective,
observational cohort study of HIV infected veterans and age, race and site-matched
controls. VACS was started in 1999 and was designed to evaluate the impact of
comorbidities and behavior on HIV outcomes. Since then it has expanded to nine urban
sites throughout the U.S., where it enrolls patients seen in infectious disease and general
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medicine clinics. VACS also includes a virtual cohort (VACS-VC), a nationally
representative sample of HIV-infected veterans and matched uninfected controls
identified through the VA electronic medical record (EMR) system and followed since
1996 [17, 18]. For this analysis, we derived our sample from the VACS-VC.

Demographic data, medical diagnoses (based on International Classification of Diseases,
Ninth Revision, Clinical Modification [ICD-9-CM] codes), and laboratory results were
extracted from VA EMR. Medicare and/or Medicaid enrollment and utilization for these
veterans were extracted from data provided by the Center for Medicare & Medicaid
Services (CMS). The study received approval from the Human Investigations Committee
at Yale University and the Human Studies Subcommittee of the VA Connecticut
Healthcare System and was granted a waiver of informed consent.

We started with a source population that included all veterans enrolled in the VACS-VC
prior to January 1, 2003 (cohort 1 in Figure 1) and engaged in VA care. For the purpose
of this analysis, we defined engaged in care as at least one inpatient or outpatient visit to
a VA medical center in 2003. Using CMS enrollment data, we determined the frequency
of Medicare and/or Medicaid enrollment in this cohort. To study frequency and drivers of
CMS use, we limited our cohort of VA enrolled veterans to include only those with
coverage for CMS use. We narrowed our sample to veterans that were CMS enrolled in
the 2004 and 2005 calendar years, and had at least one inpatient admission in either VA
or non-VA hospitals during this same period. From this group, we excluded those CMS
enrolled for less than 18 months in the 24-month period, enrolled in HMO plans (as
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defined in the CMS data file), and enrolled in Medicaid in more than one state. Finally,
we excluded female veterans, due to their low numbers in our final sample (cohort 2 in
FIGURE 1: Cohort development for 2004 dual enrollment and dual use in 20042005

1

Veterans Aging Cohort Study Virtual Cohort
Veterans Administration
3
4827 veterans excluded because died in 2004 or 2005
4
Health Maintenance Organization
5
Fee-for-service
2

10

Figure 1). Our final sample consisted of 7,765 male HIV infected and uninfected
veterans enrolled in FFS Medicare and/or Medicaid, with at least one inpatient admission
in 2004 and 2005. We used this cohort to determine the frequency and predictors of nonVA hospital admissions.

We created a series of variables to identify factors associated with non-VA hospital
admissions among male veterans, who were enrolled in fee for service (FFS) Medicare
and/or Medicaid, and who received inpatient care in 2004 and 2005 (cohort 2). Our
dependent variable was a dichotomous indicator of any non-VA admissions, (vs. only VA
inpatient admissions). Hospital admissions were identified by combining VA EMR data
with CMS FFS reimbursement files.

We considered a number of independent variables that could possibly influence use of
non-VA inpatient care, including demographic factors, access to care, illness severity,
and admission to a medical or surgical intensive care unit (ICU). Age and race data were
taken from VA administrative databases. Age was constructed as a dichotomous variable:
under age 65 and 65 years and older. Race was divided into three categorical variables:
White, African American, and Other.

Patients’ access to care was measured by three variables: a) enrollment in Medicare,
Medicaid, or both programs; b) distance to nearest VA tertiary care center treated as a
categorical variable: 0 to 9.9 miles, 10-29.9 miles, 30-59.9 miles, 60-119.9 miles, and
greater than 120 miles [19]; and an indicator of whether veterans were subject to co-pays
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for VA care. Co-pay status was in turn determined using data on service connection,
medical conditions, and an income-based “means test” for each veteran.

We used the CMS hierarchical condition categories (HCC) model to calculate risk scores
[20], and used the scores as a measure of patients’ illness severity. The HCC model is a
risk adjustment method employed by CMS to predict prospective payments for patients
based on the previous year’s claims data, using patient demographics and major medical
conditions; it has been applied to the VA population in the past for similar analyses [7].
Each year the average risk score is set at one, and we divided our HCC risk scores into a
dichotomous variable: scores greater than one and scores less than or equal to one. We
created a binary variable for HIV status, identified through VA administrative data. We
also used VA administrative data to identify veterans that carried a diagnosis of a
substance use problem (illicit substance abuse or dependence), using ICD-9CM codes
and a previously validated algorithm available on the VACS website (vacohort.org).

We generated categorical variables for number of inpatient admissions (one vs. two or
more) and the admission diagnosis (ICU vs. non-ICU admission), because we believe
both could influence the likelihood of a veteran having a non-VA admission. Veterans
with more frequent admissions have more “opportunities” to be hospitalized in a non-VA
facility. Similarly, patients in critical condition, requiring admission to ICUs, may be
more likely to be routed to a non-VA hospital. Though these variables do not reflect
patient behavior, they may influence the likelihood of an admission outside the VA and,
thus, we controlled for these factors in our model.
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Analysis
We first examined veterans in the VACS-VC (cohort 1) to determine the frequency of
CMS enrollment among veterans engaged in care. We stratified our analysis by age and
HIV status, and used student t-tests to compare the frequency of CMS enrollment
between HIV-infected and uninfected veterans. Next, we described the cohort of male,
veterans enrolled in FFS Medicare and/or Medicaid with at least one inpatient admission
(cohort 2) using the independent variables listed above. We stratified cohort 2 by HIV
status, and used chi-square tests to compare the two sub-populations. Finally, we
explored the unadjusted and adjusted association between these independent variables
and non-VA hospital admissions using logistic regression. We created a multivariate
model that included all patients in cohort 2, as well as separate models stratified by HIV
status. All analyses were conducted using SAS version 9.2.

Results
Overall, HIV-infected veterans engaged in VA care were more likely than uninfected
veterans to be enrolled in Medicare and/or Medicaid (38% vs. 33%, p<0.01) (Table 1).
Whereas HIV-infected veterans under age 65 were more likely to be CMS enrolled than
uninfected veterans, (36% vs. 29%, p<0.01), HIV-infected veterans 65 years and older
were less likely to be CMS enrolled (53% vs. 70%, p<0.01). The majority of CMS
enrolled veterans were enrolled in Medicare, but HIV-infected veterans were more likely
than uninfected veterans to be enrolled in Medicaid, either alone or in combination with
Medicare.
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TABLE 1: Medicare and/or Medicaid enrollment among veterans enrolled in VACSVC1 in 2004
ALL
PATIENTS
n (%)

HIV+
n (%)

HIVn (%)

n=91369

n=29909

n=61460

Medicare Only

20964 (23)

6461 (22)

14503 (24)

<.0001

Medicaid Only

5220 (6)

2203 (7)

3017 (5)

<.0001

Medicare and Medicaid

5290 (6)

2618 (9)

2672 (4)

<.0001

31474 (34)

11282 (38)

20192 (33)

<.0001

n=82835

n=27193

n=55642

Medicare Only

16309 (20)

5334 (20)

10975 (20)

0.7111

Medicaid Only

5187 (6)

2190 (8)

2997 (5)

<.0001

Medicare and Medicaid

4475 (5)

2329 (9)

2146 (4)

<.0001

Total Enrolled in CMS

25971 (31)

9853 (36)

16118 (29)

<.0001

n=8534

n=2716

n=5818

Medicare Only

4655 (55)

1127 (41)

3528 (61)

<.0001

Medicaid Only

33 (0)

13 (0)

20 (0)

0.3497

Medicare and Medicaid

815 (10)

289 (11)

526 (9)

0.0192

Total Enrolled in CMS

5503 (64)

1429 (53)

4074 (70)

<.0001

Total Unique in VACS-VC

Total Enrolled in CMS

2

Under 65

65 and over

1
2

p-value

Veterans Aging Cohort Study – Virtual Cohort
Center for Medicare & Medicaid Service

Among veterans enrolled in FFS Medicare and/or Medicaid with at least one inpatient
admission (cohort 2), the frequency of non-VA hospitalizations among HIV-infected
veterans was lower than the frequency among uninfected veterans (48% vs.54%, p<0.01)
(Table 2). Compared to uninfected veterans, HIV-infected veterans were younger and
lived closer to VA hospitals. A greater proportion of HIV-infected veterans also reported
African American race, had an HCC score greater than 1, and carried a diagnosis of
substance use problem.
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TABLE 2: CMS1 enrolled veterans with 1 or more inpatient admissions in 2004 and
2005
ALL PATIENTS n (%)
n=7765

HIV+ n (%)
n=2799

HIV- n (%)
n=4966

p-value

<65
≥65

6319 (81)
1446 (19)

2405 (86)
394 (14)

3914 (79)
1052 (21)

<.0001

White
African American
Other
Distance from VA
0-9.9 miles
10-29.9 miles
30-59.9 miles
60-119.9 miles
≥120 miles
Co-pay status
No Co-pay
Co-pay
ENROLLMENT
Medicare Only
Medicaid Only
Medicare and Medicaid
HEALTH
HIV
Positive
Negative
HCC Risk Score2
<1
≥1
INPATIENT ADMISSIONS
Number of Admissions
1
≥2
ICU3 Admission
Yes
No
Substance Abuse
Yes
No
UTILIZATION
VA4 Admissions Only
Non-VA Admission

3903 (50)
3755 (48)
107 (2)

1343 (48)
1413 (50)
43 (2)

2560 (52)
2342 (47)
64 (1)

0.009

3253 (42)
1824 (24)
1270 (16)
1192 (15)
224 (3)

1445 (52)
599 (21)
393 (14)
310 (11)
52 (2)

1808 (36)
1225 (25)
877 (18)
882 (18)
172 (3)

<.0001

7174 (95)
352 (5)

2592 (96)
112 (4)

4582 (95)
240 (5)

0.0997

6408 (83)
469 (6)
888 (11)

2088 (74)
274 (10)
437 (16)

4320 (87)
195 (4)
451 (9)

<.0001

4129 (53)
3636 (47)

1040 (37)
1759 (63)

3089 (62)
1877 (38)

<.0001

3186 (41)
4579 (59)

1091 (39)
1708 (61)

2095 (42)
2871 (58)

0.0058

1637 (21)
6128 (79)

575 (21)
2224 (79)

1062 (21)
3904 (79)

0.3822

1958 (25)
5807 (75)

828 (30)
1971 (70)

1130 (23)
3836 (77)

<.0001

3757 (48)
4008 (52)

1467 (52)
1332 (48)

2290 (46)
2676 (54)

<.0001

DEMOGRAPHICS
Age

Race

2799 (36)
4966 (64)

1

Center for Medicare & Medicaid Serivces
Hierarchical Conditional Category Risk Score
3
Intensive Care Unit
4
Veterans Administration
2
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In unadjusted analysis, HIV-infected veterans had lower odds of non-VA hospitalizations
than uninfected veterans (OR=0.78 [95% CI: 0.71, 0.85]) (Table 3). In addition, older
veterans and veterans with higher HCC risk scores had greater odds of CMS use than
their respective younger and healthier counterparts. Among HIV-infected veterans, a
substance abuse diagnosis was associated with increased non-VA use (OR=1.34 [95%
CI: 1.14, 1.58]); a significant association was not found between substance abuse and
non-VA use in uninfected veterans (OR=0.91 [95% CI: 0.80, 1.04]).

The association between HIV status and decreased odds of non-VA admissions remained
in the multivariable model (OR=0.76 [95% CI: 0.68, 0.85]), whereas the association
between higher HCC risk score and increased non-VA use was not significant (Table 4).
We posited that number of admissions, which had the greatest marginal effect (OR=3.10
[95% CI: 2.79, 3.45])on the multivariate model, was masking the effects of other
variables. When we removed number of admissions from the adjusted model (analysis
not shown), both higher HCC risk score and African American race had significant
associations with increased non-VA use (OR=1.28 [95% CI: 1.13, 1.44] and OR= 1.18
[95% CI: 1.05, 1.33], respectively).

When stratifying by HIV statuses, the predictors of CMS use were similar in both the
HIV-infected and uninfected models (Table 4).

16

TABLE 3: Characteristics associated with non-VA inpatient admissions in 2004 and 2005,
bivariate analysis
ALL PATIENTS

p-value

HIV+

p-value

HIV-

p-value

DEMOGRAPHICS
Age
<65
≥65

Ref
1.86 (1.65-2.09)

<.0001

Ref
1.39 (1.12-1.72)

0.0028

Ref
2.05 (1.77-2.36)

<.0001

Ref
0.96 (0.87-1.04)
3.40 (2.13-5.41)

0.3126
<.0001

Ref
1.08 (0.93-1.26)
3.39 (1.70-6.79)

0.3031
0.0006

Ref
0.90 (0.81-1.01)
3.58 (1.90-6.74)

0.0696
<.0001

Ref
1.30 (1.16-1.46)
1.75 (1.54-2.00)
2.55 (2.22-2.93)
2.41 (1.82-3.20)

<.0001
<.0001
<.0001
<.0001

Ref
1.16 (0.96-1.40)
1.45 (1.16-1.81)
1.92 (1.49-2.46)
2.95 (1.62-5.37)

0.1297
0.0012
<.0001
0.0004

Ref
1.37 (1.19-1.59)
1.91 (1.62-2.25)
2.82 (2.38-3.34)
2.26 (1.63-3.12)

<.0001
<.0001
<.0001
<.0001

Ref
2.58 (2.04-3.27)

<.0001

Ref
1.92 (1.30-2.84)

0.001

Ref
3.01 (2.22-4.08)

<.0001

Ref
1.94 (1.60-2.36)
2.40 (2.07-2.79)

<.0001
<.0001

Ref
2.51 (1.94-3.27)
2.95 (2.38-3.68)

<.0001
<.0001

Ref
1.75 (1.30-2.36)
2.26 (1.83-2.80)

0.0003
<.0001

0.0039

Ref
1.21 (1.08-1.36)

0.0014

<.0001

Ref
2.64 (2.35-2.97)

<.0001

Race
White
African American
Other
Distance from VA
0-9.9 miles
10-29.9 miles
30-59.9 miles
60-119.9 miles
≥120 miles
Co-pay status
No Co-pay
Co-pay
ENROLLMENT
Medicare
Medicaid
Medicare and Medicaid
HEALTH
HIV
Positive
Negative
HCC Risk Score1
<1
≥1
INPATIENT ADMISSIONS
Number of Admissions
1
≥2
ICU2 Admission
Yes
No
Substance Abuse
Yes
No
1
2

0.78 (0.71-0.85)
Ref

<.0001

Ref
1.14 (1.04-1.25)

0.004

Ref
1.26 (1.08-1.46)

Ref
3.06 (2.79-3.37)

<.0001

Ref
4.29 (3.64-5.06)

2.21 (1.97-2.47)
Ref

<.0001

2.00 (1.66-2.42)
Ref

<.0001

2.34 (2.02-2.70)
Ref

<.0001

1.04 (0.94-1.15)
Ref

0.4531

1.34 (1.14-1.58)
Ref

0.0004

0.91 (0.80-1.04)
Ref

0.1549

Hierarchical Conditional Category Risk Score
Intensive Care Unit
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TABLE 4: Characteristics associated with non-VA inpatient admissions in 2004 and 2005,
multivariate analysis
ALL PATIENTS

p-value

HIV+

p-value

HIV-

p-value

DEMOGRAPHICS
Age
<65
≥65

Ref
1.90 (1.65-2.17)

<.0001

Ref
1.61 (1.25-2.08)

0.0002

Ref
2.00 (1.70-2.35)

<.0001

Ref
1.05 (0.94-1.16)
3.17 (1.91-5.27)

0.4032
<.0001

Ref
1.02 (0.86-1.22)
3.58 (1.63-7.85)

0.8293
0.0015

Ref
1.07 (0.94-1.22)
2.98 (1.52-5.83)

0.3128
0.0015

Ref
1.51 (1.33-1.72)
2.08 (1.79-2.41)
3.42 (2.92-4.01)
3.06 (2.23-4.19)

<.0001
<.0001
<.0001
<.0001

Ref
1.41 (1.13-1.75)
1.78 (1.38-2.30)
3.06 (2.29-4.09)
5.67 (2.90-11.06)

0.0022
<.0001
<.0001
<.0001

Ref
1.59 (1.35-1.86)
2.25 (1.87-2.70)
3.62 (2.99-4.37)
2.61 (1.83-3.74)

<.0001
<.0001
<.0001
<.0001

Ref
2.66 (2.05-3.46)

<.0001

Ref
2.61 (1.68-4.05)

<.0001

Ref
2.76 (1.99-3.84)

<.0001

Ref
2.83 (2.28-3.52)
2.50 (2.11-2.95)

<.0001
<.0001

Ref
2.93 (2.17-3.94)
2.89 (2.27-3.69)

<.0001
<.0001

Ref
2.57 (1.85-3.57)
2.17 (1.72-2.73)

<.0001
<.0001

0.5937

Ref
1.01 (0.88-1.15)

0.9127

<.0001

Ref
2.62 (2.30-2.98)

<.0001

Race
White
African American
Other
Distance from VA
0-9.9 miles
10-29.9 miles
30-59.9 miles
60-119.9 miles
≥120 miles
Co-pay status
No Co-pay
Co-pay
ENROLLMENT
Medicare
Medicaid
Medicare and Medicaid
HEALTH
HIV
Positive
Negative
HCC Risk Score1
<1
≥1
INPATIENT ADMISSIONS
Number of Admissions
1
≥2
ICU2 Admission
Yes
No
Substance Abuse
Yes
No
1
2

0.76 (0.68-0.85)
Ref

<.0001

Ref
0.99 (0.89-1.10)

0.8071

Ref
0.95 (0.79-1.14)

Ref
3.10 (2.79-3.45)

<.0001

Ref
4.45 (3.69-5.37)

1.73 (1.52-1.96)
Ref

<.0001

1.42 (1.15-1.76)
Ref

0.0012

1.94 (1.65-2.27)
Ref

<.0001

1.16 (1.03-1.31)
Ref

0.0179

1.28 (1.05-1.55)
Ref

0.0138

1.08 (0.92-1.26)
Ref

0.3356

Hierarchical Conditional Category Risk Score
Intensive Care Unit
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Discussion
In our sample of veterans engaged in VA care, we found that HIV-infected veterans were
more likely than their uninfected counterparts to be enrolled in Medicare and/or
Medicaid, but this difference varied by age. HIV-infected veterans under age 65 were
more likely to be CMS enrolled, whereas HIV-infected veterans 65 years and older were
much less likely to be CMS enrolled. Confirming our a priori hypothesis, we also found
that male, HIV-infected veterans enrolled in FFS Medicare and/or Medicaid were less
likely to have a non-VA hospitalization. This pattern was evident despite the fact that
these veterans were generally sicker, more likely to have multiple admissions, and more
likely to be enrolled in FFS Medicaid – all independent risk factors for greater non-VA
use.

We suspect that HIV-infected veterans were less likely to use non-VA hospitals because
they feel more tied to the VA – possibly due to the integrated care and various providers
they see in VA infectious disease clinics, or the desire for continuity with established
caregivers for what is historically a stigmatized disease. The prescription drug coverage
afforded veterans – and the high costs of antiretroviral therapy – may also play a
significant role. Although every state provides some coverage for antiretroviral drugs, the
coverage varies substantially; very few states cover as many of these drugs as are covered
nationally within VA. This explanation is also supported from patient self report data in
VACS8 in which 96% of those on ART reported getting all their antiretroviral
medications through VA [17].
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Our findings on frequency of CMS enrollment among veterans were not completely
consistent with previous literature. Overall, we found lower rates of Medicare enrollment,
but higher rates of enrollment in Medicaid [21]. This difference was particularly evident
among veterans 65 years and older, for whom Medicare enrollment has been reported to
be greater than 90% [7, 21]. Our results are likely driven primarily by our initial cohort
(cohort 1), which included only patients who were already engaged in VA care, i.e. were
seen at the VA at least once in the past year. We suspect that veterans already receiving
care at the VA are less likely to seek alternative forms of coverage than all veterans ever
enrolled in VA care. The difference may also be partially attributed to the greater share of
HIV-infected veterans in our sample than in previously studied groups. VACS-VC is a
nationally representative sample of HIV-infected veterans, not all veterans enrolled in
VA care. As noted in the background section, HIV-infected veterans differentially qualify
for Medicare coverage, primarily through disability [10]. Similarly, we believe that
comorbid and socioeconomic factors that contribute to higher rates of Medicaid
enrollment among all persons living with HIV contributed to the higher rates of Medicaid
enrollment in our sample of veterans. Among HIV infected and uninfected veterans,
some of these changes may also be partially driven by a change in the population
utilizing VA care since 1999 [8, 21], when previous reports were published. Our results
are based on data from from five years later, and may also reflect an evolving perception
of VA care or increased Medicare cost sharing.

Our findings regarding predictors of non-VA hospitalization among CMS enrolled
veterans engaged in VA care were consistent with previous literature. In general, these
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studies have found older age, increased distance to the VA, greater cost-sharing and
worse health to be associated with non-VA use [7,8, 22,23]. Our results confirm these
findings among HIV-infected veterans, and serve as a reminder to VA care providers
regarding patients that are more likely to receive non-VA care and thus benefit from care
coordination efforts with outside providers.

Our results should be viewed in light of several limitations – most importantly, our
limited access to data on private insurance enrollment and utilization in the VA
population. As a result of the lack of claims data for patients hospitalized under private
insurance, some patients classified as having only VA admissions may actually have
unaccounted for admissions to non-VA hospitals. Moreover, CMS enrollment with
private insurance may lead to significantly lower costs for veterans, influencing their
choice of health care setting. The VACS does collect some survey data on private
insurance enrollment. Among veterans in VACS8, 15% of HIV-infected veterans and
20% of uninfected veterans reported enrollment in private insurance (analysis not
shown). Given the lower rates of supplemental insurance in the HIV-infected population,
we believe our finding that HIV-infected veterans are less likely to have non-VA
admissions likely still holds true. Another limitation is that inpatient admissions are
commonly influenced by factors beyond patient preference. Although we controlled for
those variables in our analysis, inpatient admissions as an outcome variable may limit the
conclusions that can be drawn from our results. We chose inpatient admissions because
non-VA inpatient care places HIV-infected veterans at risk for adverse events, related to
poor coordination of care transitions between outside hospitals and VHA HIV clinics. We
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recognize, however, that choice in outpatient setting may be a better reflection of patient
preferences (and will be the subject of future studies). We also did not take into account
pathways to CMS enrollment. Veterans that were enrolled in Medicare or Medicaid prior
to engagement with the VA system may be more likely to have non-VA admissions; the
opposite may be true of veterans that were seeking care with the VA prior to enrolling
with Medicare and/or Medicaid. In addition, though most HIV infected people with
Medicare qualify through disability, it is unknown if this association is also true among
veterans.

The heterogeneity of Medicare and/or Medicaid from state to state also limits our ability
to generalize the data. Medicare Advantage plans, i.e. managed care plans provided by
private insurers, are highly variable by design, and Medicaid benefits and eligibility vary
from state to state. Moreover, to date only 26 of the 50 states have chosen to accept the
ACA provision to expand Medicaid, making comparisons between states more difficult in
the post-ACA era. Finally, our findings are limited by the age of our data. We restricted
our analysis to 2004 and 2005, the latest years we had complete data available.
Nonetheless, our analysis uses more recent data than similar studies analyzing CMS
enrollment and CMS use.

Conclusion
Many veterans engaged in care in the VA are also enrolled in Medicare and/or Medicaid,
including a significant proportion of veterans under age 65. Like the general population,
the rates of CMS enrollment are higher among HIV infected veterans. Among veterans
enrolled in both VA and CMS care, however, HIV-infected veterans have lower odds of
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non-VA hospitalization – despite having greater illness severity and more frequent
hospitalizations than uninfected veterans. The VA’s integrated model of care used to treat
HIV/AIDS may explain why HIV-infected veterans were more likely to seek care within
the VA.

The impact of CMS use on veterans with HIV and other complex medical conditions
requires further investigation. HIV-infected veterans have complicated medical histories
and are likely to experience inefficient care and poor outcomes related to non-VA use.
Research that provides evidence of the cost and health implications of CMS use may
guide the VA in how aggressively to pursue and try to retain these patients in the VA
system.

Future research should also explore why veterans with HIV were less likely than
uninfected veterans to use non-VA care. If specific aspects of VA’s integrated care
programs for veterans with HIV, such as intensive case management, are found to
contribute to lower likelihood of non-VA admission, then this would inform strategies to
limit non-VA use among other veteran populations at high risk from fragmented care,
such as veterans with other major chronic diseases or illnesses.

CMS enrollment is a valuable resource for veterans who face higher copayments or live
long distances from VA medical centersyet among some veterans, CMS enrollment may
lead to inefficient care and poor health outcomes. As health coverage is further expanded,
efforts should be made to ensure that additional coverage is reaching the populations that
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can benefit the most. The VA and federal government should shape their policies to
incentivize use of a single health system, and also develop procedures to ensure
comprehensive exchange of information between health systems.
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